The FDASIA, the risk-based regulatory framework of the FDA, has been called into question by a number of healthcare tech groups. Published in April, the report has drawn criticism from the American Hospital Association for failing to address “interoperability of information across data sources; product usability; and accurate patient matching”. Both the College of Healthcare Information Management Executives,
